{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:28:59Z","timestamp":1771014539877,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1986,2,1]],"date-time":"1986-02-01T00:00:00Z","timestamp":507600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Toxicology"],"published-print":{"date-parts":[[1986,2]]},"DOI":"10.1007\/bf03259825","type":"journal-article","created":{"date-parts":[[2016,2,7]],"date-time":"2016-02-07T20:29:17Z","timestamp":1454876957000},"page":"12-31","source":"Crossref","is-referenced-by-count":42,"title":["Acute Poisoning Due to Non-Steroidal Anti-Inflammatory Drugs"],"prefix":"10.1007","volume":"1","author":[{"given":"J. A.","family":"Vale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. J.","family":"Meredith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,27]]},"reference":[{"key":"BF03259825_CR1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2165\/00003088-197803050-00003","volume":"3","author":"J Aarbakke","year":"1978","unstructured":"Aarbakke J. Clinical pharmacokinetics of phenylbutazone. Clinical Pharmacokinetics 3: 369\u2013380, 1978","journal-title":"Clinical Pharmacokinetics"},{"key":"BF03259825_CR2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/cpt1975183364","volume":"18","author":"G Alvan","year":"1975","unstructured":"Alvan G, Orme M, Bertilsson L, Ekstrand R, Palmer L. Pharmacokinetics of indomethacin. Clinical Pharmacology and Therapeutics 18: 364\u2013373, 1975","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259825_CR3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/106002808101500210","volume":"15","author":"DH Appleby","year":"1981","unstructured":"Appleby DH. Fenoprofen (Nalfon) overdose. Drug Intelligence and Clinical Pharmacy 15: 129\u2013130, 1981","journal-title":"Drug Intelligence and Clinical Pharmacy"},{"key":"BF03259825_CR4","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/S0140-6736(81)92528-9","volume":"1","author":"M Balali-Mood","year":"1981","unstructured":"Balali-Mood M, Critchley JAJH, Proudfoot AT, Prescott LF. Mefenamic acid overdosage. Lancet 1: 1354\u20131356, 1981","journal-title":"Lancet"},{"key":"BF03259825_CR5","first-page":"35","volume-title":"American Journal of Medicine, Symposium","author":"WS Barry","year":"1984","unstructured":"Barry WS, Meinzinger MM, Howse CR. Ibuprofen overdose and exposure in utero: results from a post-marketing voluntary reporting system. American Journal of Medicine, Symposium, July 13, pp. 35\u201339, 1984"},{"key":"BF03259825_CR6","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1542\/peds.17.6.967","volume":"17","author":"T Bates","year":"1956","unstructured":"Bates T. Phenylbutazone. Pediatrics 17: 967\u2013968, 1956","journal-title":"Pediatrics"},{"key":"BF03259825_CR7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.7326\/0003-4819-96-3-334","volume":"96","author":"WG Berlinger","year":"1982","unstructured":"Berlinger WG, Spector R, Flanigan MJ, Johnson GF, Groh MR. Hemoperfusion for phenylbutazone poisoning. Annals of Internal Medicine 96: 334\u2013335, 1982","journal-title":"Annals of Internal Medicine"},{"key":"BF03259825_CR8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2165\/00003495-197714040-00001","volume":"14","author":"RN Brogden","year":"1977","unstructured":"Brogden RN, Heel RC, Speight TM, Avery GS. Alclofenac: a review of its pharmacological properties and therapeutic efficacy in rheumatoid arthritis and allied rheumatic disorders. Drugs 14: 241\u2013259, 1977","journal-title":"Drugs"},{"key":"BF03259825_CR9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003495-197815060-00002","volume":"15","author":"RN Brogden","year":"1978","unstructured":"Brogden RN, Heel RC, Speight TM, Avery GS. Tolmetin: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases. Drugs 15: 429\u2013450, 1978","journal-title":"Drugs"},{"key":"BF03259825_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-198121010-00001","volume":"21","author":"RN Brogden","year":"1981","unstructured":"Brogden RN, Heel RC, Speight TM, Avery GS. Fenbufen: a review of its pharmacological properties and therapeutic use in rheumatic disease and acute pain. Drugs 21: 1\u201322, 1981","journal-title":"Drugs"},{"key":"BF03259825_CR11","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0021-9673(00)82431-0","volume":"243","author":"RD Budd","year":"1982","unstructured":"Budd RD. Gas Chromatographic determination of butazolidin (phenylbutazone) in biological fluids. Journal of Chromatography 243: 368\u2013371, 1982","journal-title":"Journal of Chromatography"},{"key":"BF03259825_CR12","doi-asserted-by":"crossref","first-page":"478","DOI":"10.5694\/j.1326-5377.1983.tb136171.x","volume":"1","author":"RW Bury","year":"1983","unstructured":"Bury RW, Mashford ML, Glaun BP, Saaroni G. Acute phenylbutazone poisoning in a child. Medical Journal of Australia 1: 478\u2013479, 1983","journal-title":"Medical Journal of Australia"},{"key":"BF03259825_CR13","volume-title":"Pharmacological and biochemical properties of drug substances","author":"RJ Capetola","year":"1981","unstructured":"Capetola RJ, Argentieri D, Weintraub HS, Chasin M, Doyle P, et al. Suprofen. In Goldberg ML (Ed.) Pharmacological and biochemical properties of drug substances, Vol. 3, American Pharmaceutical Association, Academy of Pharmaceutical Sciences, Washington DC, 1981"},{"key":"BF03259825_CR14","first-page":"728","volume":"30","author":"FS Chiccarelli","year":"1980","unstructured":"Chiccarelli FS, Eisner HJ, Van Lear GE. Metabolic and pharmacokinetic studies with fenbufen in man. Arzneimittel-Forschung 30: 728\u2013735, 1980","journal-title":"Arzneimittel-Forschung"},{"key":"BF03259825_CR15","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/bmj.282.6269.1073-a","volume":"282","author":"H Court","year":"1981","unstructured":"Court H, Streete PJ, Volans GN. Overdose with ibuprofen causing unconsciousness and hypotension. British Medical Journal 282: 1073, 1981","journal-title":"British Medical Journal"},{"key":"BF03259825_CR16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/096032718300200234","volume":"2","author":"H Court","year":"1983","unstructured":"Court H, Streete P, Volans GN. Acute poisoning with ibuprofen. Human Toxicology 2: 381\u2013384, 1983","journal-title":"Human Toxicology"},{"key":"BF03259825_CR17","first-page":"1","volume":"3","author":"H Court","year":"1984","unstructured":"Court H, Volans GN. Poisoning after overdose with non-steroidal anti-inflammatory drugs. Adverse Drug Reactions and Acute Poisoning Reviews 3: 1\u201321, 1984","journal-title":"Adverse Drug Reactions and Acute Poisoning Reviews"},{"key":"BF03259825_CR18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0022-3565(25)29239-4","volume":"181","author":"DE Duggan","year":"1972","unstructured":"Duggan DE, Hogans AF, Kwan KC, McMahon FG. The metabolism of indomethacin in man. Journal of Pharmacology and Experimental Therapeutics 181: 563\u2013575, 1972","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"BF03259825_CR19","unstructured":"Editorial. Butazolidin fatality. Pharmaceutical Journal 194: 604, 1965"},{"key":"BF03259825_CR20","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1365-2125.1985.tb02724.x","volume":"19","author":"N El-Bahie","year":"1985","unstructured":"El-Bahie N, Allen EM, Williams J, Routledge PA. The effect of activated charcoal and hyoscine butylbromide alone and in combination on the absorption of mefenamic acid. British Journal of Clinical Pharmacology 19: 836\u2013838, 1985","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259825_CR21","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jama.238.9.938b","volume":"238","author":"EW Fredell","year":"1977","unstructured":"Fredell EW, Strand LJ. Naproxen overdose. Journal of the American Medical Association 238: 938, 1977","journal-title":"Journal of the American Medical Association"},{"key":"BF03259825_CR22","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/bmj.289.6443.470","volume":"289","author":"S Freestone","year":"1984","unstructured":"Freestone S, Critchley JAJH. Self poisoning with sutoprofen. British Medical Journal 289: 470, 1984","journal-title":"British Medical Journal"},{"issue":"Suppl. 1","key":"BF03259825_CR23","first-page":"48","volume":"23","author":"LK Garrettson","year":"1982","unstructured":"Garrettson LK, Goplerud JM, Saady JJ. Ibuprofen overdose with sedation. Veterinary and Human Toxicology 23 (Suppl. 1): 48, 1982","journal-title":"Veterinary and Human Toxicology"},{"key":"BF03259825_CR24","first-page":"317","volume":"113","author":"M Gaultier","year":"1962","unstructured":"Gaultier M, Fournier Et, Gervais P, Gorceix A, Frejaville J-P. Intoxication aigu\u00eb volontaire \u00e0 la ph\u00e9nylbutazone, Anurie, Gu\u00e9rison. Bulletins et Memoires de la Societe Medicale des Hopitaux de Paris 113: 317\u2013322, 1962","journal-title":"Bulletins et Memoires de la Societe Medicale des Hopitaux de Paris"},{"key":"BF03259825_CR25","first-page":"23","volume":"9","author":"AT Glazko","year":"1967","unstructured":"Glazko AT. Pharmacology of the fenamates. III. Metabolic disposition. Annals of Physical Medicine 9: 23\u201326, 1967","journal-title":"Annals of Physical Medicine"},{"key":"BF03259825_CR26","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0140-6736(82)90572-4","volume":"2","author":"H Gossinger","year":"1982","unstructured":"Gossinger H, Hruby K, Haubenstock A, Jung M, Zwerina N. Coma in mefenamic acid poisoning. Lancet 2: 384, 1982","journal-title":"Lancet"},{"key":"BF03259825_CR27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.7326\/0003-4819-96-6-793_2","volume":"96","author":"GE Gross","year":"1982","unstructured":"Gross GE. Granulocytosis and sulindac overdose. Annals of Internal Medicine 96: 793\u2013794, 1982","journal-title":"Annals of Internal Medicine"},{"key":"BF03259825_CR28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00003088-198106040-00001","volume":"6","author":"L Helleberg","year":"1981","unstructured":"Helleberg L. Clinical pharmacokinetics of indomethacin. Clinical Pharmacokinetics 6: 245\u2013258, 1981","journal-title":"Clinical Pharmacokinetics"},{"key":"BF03259825_CR29","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1136\/bmj.281.6253.1458-a","volume":"281","author":"DP Hunt","year":"1980","unstructured":"Hunt DP, Leigh RJ. Overdose with ibuprofen causing unconsciousness and hypotension. British Medical Journal 281: 1458\u20131459, 1980","journal-title":"British Medical Journal"},{"key":"BF03259825_CR30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1651-2227.1965.tb06407.x","volume":"54","author":"J Juul","year":"1965","unstructured":"Juul J. Acute poisoning with butazolidin. Acta Pediatrica Scandinavica 54: 503\u2013507, 1965","journal-title":"Acta Pediatrica Scandinavica"},{"key":"BF03259825_CR31","first-page":"836","volume":"34","author":"C Koppel","year":"1984","unstructured":"Koppel C, Wagemann A, Tenczer J, Muth H. Tiaprofenic acid overdose. Arzneimittel Forschung 34: 836\u2013837, 1984","journal-title":"Arzneimittel Forschung"},{"key":"BF03259825_CR32","first-page":"798","volume":"287","author":"GCC Lo","year":"1983","unstructured":"Lo GCC, Chan JYW. Piroxicam poisoning. British Medical Journal 287: 798, 1983","journal-title":"British Medical Journal"},{"key":"BF03259825_CR33","first-page":"31","volume":"66","author":"LG Macdougall","year":"1984","unstructured":"Macdougall LG, Taylor-Smith A, Rothberg AD, Thomson PD. Piroxicam poisoning in a 2-year-old child. South African Medical Journal 66: 31\u201333, 1984","journal-title":"South African Medical Journal"},{"key":"BF03259825_CR34","unstructured":"Meredith TJ, Streete P. Unpublished observations."},{"key":"BF03259825_CR35","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/bmj.290.6471.822","volume":"290","author":"DE Morris","year":"1985","unstructured":"Morris DE, Hardway RL. Visual hallucinations induced by fenbufen. British Medical Journal 290: 822, 1985","journal-title":"British Medical Journal"},{"key":"BF03259825_CR36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.0954-6820.1984.tb03814.x","volume":"216","author":"J Mosvold","year":"1984","unstructured":"Mosvold J, Meilern H, Stave R, Osnes M, Laufen H. Overdosage of piroxicam. Acta Medica Scandinavica 216: 335\u2013336, 1984","journal-title":"Acta Medica Scandinavica"},{"key":"BF03259825_CR37","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/BF00542154","volume":"26","author":"P Netter","year":"1984","unstructured":"Netter P, Lambert H, Larcan A, Godbillon J, Gosset G. Diclofenac sodium-chlormezanone poisoning. European Journal of Clinical Pharmacology 26: 535\u2013536, 1984","journal-title":"European Journal of Clinical Pharmacology"},{"key":"BF03259825_CR38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00561677","volume":"17","author":"PJ Neuvonen","year":"1980","unstructured":"Neuvonen PJ, Elonen E. Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man. European Journal of Clinical Pharmacology 17: 51\u201357, 1980","journal-title":"European Journal of Clinical Pharmacology"},{"key":"BF03259825_CR39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/bmj.287.6384.39","volume":"287","author":"G Nuki","year":"1983","unstructured":"Nuki G. Non-steroidal analgesic and anti-inflammatory agents. British Medical Journal 287: 39\u201343, 1983","journal-title":"British Medical Journal"},{"key":"BF03259825_CR40","doi-asserted-by":"crossref","first-page":"385S","DOI":"10.1111\/j.1365-2125.1980.tb01827.x","volume":"10","author":"S Okonek","year":"1980","unstructured":"Okonek S. Intoxication with pyrazolones. British Journal of Clinical Pharmacology 10: 385S\u2013390S, 1980","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259825_CR41","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2125.1984.tb02527.x","volume":"18","author":"KT Olkkola","year":"1984","unstructured":"Olkkola KT, Neuvonen PJ. Do gastric contents modify antidotal efficacy of oral activated charcoal? British Journal of Clinical Pharmacology 18: 663\u2013669, 1984","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259825_CR42","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/jps.2600660735","volume":"66","author":"J Pottier","year":"1977","unstructured":"Pottier J, Berlin D, Raynaud JP. Pharmacokinetics of the antiinflammatory tiaprofenic acid in humans, mice, rats, rabbits and dogs. Journ. of Pharm. Sciences 66: 1030\u20131036, 1977","journal-title":"Journ. of Pharm. Sciences"},{"key":"BF03259825_CR43","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.281.6248.1106","volume":"281","author":"LF Prescott","year":"1980","unstructured":"Prescott LF, Critchley JAJH, Balali-Mood M. Phenylbutazone overdosage: abnormal metabolism associated with hepatic and renal damage. British Medical Journal 281: 1106\u20131107, 1980","journal-title":"British Medical Journal"},{"key":"BF03259825_CR44","first-page":"133","volume":"239","author":"P Queneau","year":"1978","unstructured":"Queneau P, Barthelemy C, Fulchiron P. Ingestion massive d\u2019indometacine en prise unique (\u00e0 propos de 2 observations personnelles). Lyon M\u00e9dical 239: 133\u2013136, 1978","journal-title":"Lyon M\u00e9dical"},{"key":"BF03259825_CR45","first-page":"276","volume-title":"Martindale: The Extra Pharmacopoeia","author":"JES Reynolds","year":"1982","unstructured":"Reynolds JES, Prasad AB (Eds) Martindale: The Extra Pharmacopoeia, 28th ed., p.276, Pharmaceutical Press, London, 1982","edition":"28th"},{"key":"BF03259825_CR46","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3109\/00498257809069581","volume":"8","author":"PC Risdall","year":"1978","unstructured":"Risdall PC, Adams SS, Crampton EL, Marchant B. The disposition and metabolism of flurbiprofen in several species including man. Xenobiotica 8: 691\u2013704, 1978","journal-title":"Xenobiotica"},{"key":"BF03259825_CR47","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/bmj.2.6202.1438-c","volume":"2","author":"RH Robson","year":"1979","unstructured":"Robson RH, Balali M, Critchley J, Proudfoot AT, Prescott L. Mefenamic acid poisoning and epilepsy. British Medical Journal 2: 1438, 1979","journal-title":"British Medical Journal"},{"key":"BF03259825_CR48","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/jps.2600610514","volume":"61","author":"A Rubin","year":"1972","unstructured":"Rubin A, Rodda BE, Warrick P, Ridolfo AS, Gruber CM. Physiological disposition of fenoprofen in man. II. Plasma and urine pharmacokinetics after oral and intravenous administration. Journal of Pharmaceutical Sciences 61: 739\u2013749, 1972a","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"BF03259825_CR49","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0022-3565(25)29358-2","volume":"183","author":"A Rubin","year":"1972","unstructured":"Rubin A, Warrick P, Wolen RL, Chernish SM, Ridolfo AS, Gruber CM. Physiological disposition of fenoprofen in man. III. Metabolism and protein binding of fenoprofen. Journal of Pharmacology and Experimental Therapeutics 183: 449\u2013457, 1972b","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"BF03259825_CR50","first-page":"151","volume":"13","author":"A Rubin","year":"1972","unstructured":"Rubin A, Warrick P, Wolen RL, Ridolfo AS, Gruber CM. The metabolism of fenoprofen in man. Clinical Pharmacology and Therapeutics 13: 151, 1972c","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259825_CR51","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/jps.2600610507","volume":"61","author":"R Runkel","year":"1972","unstructured":"Runkel R, Chaplin M, Boost G, Segre E, Forchielli E. Absorption, distribution, metabolism and excretion of naproxen in various laboratory animals and human subjects. Journal of Pharmaceutical Sciences 61: 703\u2013707, 1972","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"BF03259825_CR52","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/cpt1976203269","volume":"20","author":"R Runkel","year":"1976","unstructured":"Runkel R, Chaplin MD, Sevelius H, Ortega E, Segre E. Pharmacokinetics of naproxen overdoses. Clinical Pharmacology and Therapeutics 20: 269\u2013277, 1976","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259825_CR53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/03009747309097093","volume":"2","author":"R Runkel","year":"1973","unstructured":"Runkel R, Forchielli E, Boost G, Chaplin M, Hill R, et al. Naproxen-metabolism, excretion and comparative pharmacokinetics. Scandinavian Journal of Rheumatology (Suppl.) 2: 29\u201336, 1973","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"BF03259825_CR54","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/cpt1974153261","volume":"15","author":"R Runkel","year":"1974","unstructured":"Runkel R, Forchielli E, Sevelius H, Chaplin M, Segre E. Nonlinear plasma level response to high doses of naproxen. Clinical Pharmacology and Therapeutics 15: 261\u2013266, 1974","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259825_CR55","volume-title":"Indomethacin poisoning","author":"T Sheehan","year":"1985","unstructured":"Sheehan T, Boldy DAR, Vale JA. Indomethacin poisoning, submitted for publication, 1985"},{"key":"BF03259825_CR56","first-page":"823","volume":"67","author":"EA Shipton","year":"1985","unstructured":"Shipton EA, Muller FO. Severe mefenamic acid poisoning. A case report. South African Medical Journal 67: 823\u2013824, 1985","journal-title":"South African Medical Journal"},{"key":"BF03259825_CR57","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2165\/00003495-198529030-00002","volume":"29","author":"EM Sorkin","year":"1985","unstructured":"Sorkin EM, Brogden RN. Tiaprofenic acid: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases and pain states. Drugs 29: 208\u2013235, 1985","journal-title":"Drugs"},{"key":"BF03259825_CR58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0002-9343(83)91161-0","volume":"75","author":"I Stachura","year":"1983","unstructured":"Stachura I, Jayakumar S, Bourke E. T and B lymphocyte subsets in fenoprofen nephropathy. American Journal of Medicine 75: 9\u201316, 1983","journal-title":"American Journal of Medicine"},{"key":"BF03259825_CR59","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1365-2044.1979.tb06256.x","volume":"34","author":"JE Strong","year":"1979","unstructured":"Strong JE, Wilson J, Douglas JF, Coppel DL. Phenylbutazone self-poisoning treated by charcoal haemoperfusion. Anaesthesia 34: 1038\u20131040, 1979","journal-title":"Anaesthesia"},{"key":"BF03259825_CR60","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF00607149","volume":"20","author":"RA Upton","year":"1981","unstructured":"Upton RA, Williams RL, Guentert TW, Buskin JN, Riegelman S. Ketoprofen pharmacokinetics and bioavailability based on an improved sensitive and specific assay. European Journal of Clinical Pharmacology 20: 127\u2013133, 1981","journal-title":"European Journal of Clinical Pharmacology"},{"key":"BF03259825_CR61","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00003088-198308040-00003","volume":"8","author":"RK Verbeeck","year":"1983","unstructured":"Verbeeck RK, Blackburn JL, Loewen GR. Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs. Clinical Pharmacokinetics 8: 297\u2013331, 1983","journal-title":"Clinical Pharmacokinetics"},{"key":"BF03259825_CR62","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/106002808301700713","volume":"17","author":"PK Waugh","year":"1983","unstructured":"Waugh PK, Keatinge DW. Hypoprothrombinaemia in naproxen overdose. Drug Intelligence and Clinical Pharmacy 17: 549\u2013550, 1983","journal-title":"Drug Intelligence and Clinical Pharmacy"},{"key":"BF03259825_CR63","first-page":"1583","volume":"109","author":"JR Weiser","year":"1984","unstructured":"Weiser JR, Botzier R, Pentz R, Siegers C-P. Klinik und verlauf einer Vergiftung mit piroxicam. Deutsche Medizinische Wochenschrift 109: 1583, 1984","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"BF03259825_CR64","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0006-2952(79)90154-0","volume":"28","author":"JB Whitlam","year":"1979","unstructured":"Whitlam JB, Crooks MJ, Brown KP, Veng Pedersen P. Binding of nonsteroidal anti-inflammatory agents to proteins. I. Ibuprofen \u2014 serum albumin interaction. Biochemical Pharmacology 28: 675\u2013678, 1979","journal-title":"Biochemical Pharmacology"},{"key":"BF03259825_CR65","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF00568201","volume":"16","author":"JV Willis","year":"1979","unstructured":"Willis JV, Kendall MJ, Flinn RM, Thornhill DP, Welling PG. The pharmacokinetics of diclofenac sodium following intravenous and oral administration. European Journal of Clinical Pharmacology 16: 405\u2013410, 1979","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"2A","key":"BF03259825_CR66","first-page":"9","volume":"72","author":"EH Wiseman","year":"1982","unstructured":"Wiseman EH, Hobbs DC. Review of pharmacokinetic studies with piroxicam. American Journal of Medicine 72(2A): 9\u201317, 1982","journal-title":"American Journal of Medicine"},{"key":"BF03259825_CR67","first-page":"83","volume":"3","author":"T Wramner","year":"1957","unstructured":"Wramner T. A case of poisoning with 10 grams of butazolidin. Acta Rheumatologica Scandinavica 3: 83\u201391, 1957","journal-title":"Acta Rheumatologica Scandinavica"},{"key":"BF03259825_CR68","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/bmj.2.6191.672-a","volume":"2","author":"RJ Young","year":"1979","unstructured":"Young RJ. Mefenamic acid poisoning and epilepsy. British Medical Journal 2: 672, 1979","journal-title":"British Medical Journal"}],"container-title":["Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259825.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03259825\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259825","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T09:52:27Z","timestamp":1748771547000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03259825"}},"subtitle":["Clinical Features and Management"],"short-title":[],"issued":{"date-parts":[[1986,2]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1986,2]]}},"alternative-id":["BF03259825"],"URL":"https:\/\/doi.org\/10.1007\/bf03259825","relation":{},"ISSN":["0112-5966"],"issn-type":[{"value":"0112-5966","type":"print"}],"subject":[],"published":{"date-parts":[[1986,2]]}}}